BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Lipopolysaccharide
,
rs7903146
,
PDX1
,
Arthritis
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
kidney neoplasms
Summary
General Info
Curated Studies
Most Correlated Studies
GSK cancer cell line transcript profiling
OMIM - Cancer
OMIM - Malignant neoplasms
Infantile Fibrosarcoma/Congenital Mesoblastic Nephroma - a comparison with other kidney tumors
Renal cell carcinoma 786-O or prostate carcinoma PC3 cells co-cultured with primary murine myoblasts
Explore Curated Studies Results
Literature
Most Relevant Literature
Are Renal Tumor Diagnostics Becoming Too Advanced for Many Pathology Laboratories?
Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP…
Percutaneous ablation of renal tumors: Long-term outcomes.
Papillary renal neoplasm with reverse polarity: a clinicopathological analysis].
Morphological and molecular portrait hybrid renal tumors].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
EUS-guided RFA for Solid Abdominal Neoplasms
EUS-guided RFA for Pancreatic Neoplasms
Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging
The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ